ETFsFTSE All-Share Index
State Street / SPDR
State Street® SPDR® FTSE UK All Share UCITS ETF (Acc)
SPYF XETRAAccumulatingPhysical, full replicationIrelandNot PEA-eligible
Last close · EUR
112.76EUR
-0.34% · -€0.38
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
SPYFBase
- Fund charges
- 0.20%PRIIPs ongoing costs
- Fund size
- €866.5Mall share classes
- Return 1Y
- +20.3%
- Sharpe 3Y
- 1.20
- Volatility 1Y
- 11.9%annualised
- Holdings
- 496Fund holdings
Performance
Compare
- SPYF+20.3%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| SPYF | +4.5% | +3.0% | +11.5% | +16.8% | +20.3% | +65.4% | +68.2% |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.0% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +7.3% | +3.6% | +3.7% | +2.7% | +6.3% | -0.2% | +3.3% |
Risk and return
Sharpe ratio · 3Y
1.20
In line with MSCI World · 1.24- Return p.a.
- +18.1%
- Volatility
- 12.1%
- Max loss
- -17.2%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
SPYF
1.20
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 43.0%
- Holdings
- 496
- As of
- 1HSBC Holdings PlcGB00054052867.75%
- 2Shell PlcGB00BP6MXD847.59%
- 3AstraZeneca PLCGB00098952927.21%
- 4Rolls-Royce Holdings plcGB00B63H84913.63%
- 5Unilever PLCGB00BVZK7T903.55%
- 6British American Tobacco p.l.c.GB00028758043.23%
- 7BP PLCGB00079805913.07%
- 8GSK plcGB00BN7SWP632.59%
- 9Rio Tinto plcGB00071887572.20%
- 10National Grid plcGB00BDR05C012.17%
Countries
Classified 99.1%
United Kingdom99.0%
- Largest
- 99.0%United Kingdom
- Top 3
- 99.1%
- Effective number
- 1.01 / HHI
Market cap
Weight vs holdings
43.0%of the fund sits in the top 10 holdings
43.0%36.0%16.4%
WeightHoldings
40150296
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
